Blog 2_P2

Thriving on Weight Loss Medications: 5 Pillars for Lasting Results

Photo by Elena Leya on Unsplash

In Part 1 of this blog series, we explored what weight loss medications, including GLP-1–based and dual GIP/GLP-1 treatments, are doing inside your body, and why they are only half the story when it comes to health and long term results.

Now let’s talk about what you can actually do to support yourself while you’re on them.

In my 7-module group program, we go into each of these areas in much more depth, with handouts, example meals, trackers, and practical tools. Here, I want to give you an overview of the five key pillars I focus on to help clients thrive while on these medications.

Pillar 1: Smart Nutrition When Appetite Is Low

One of the most common things I hear is:

“I’m just not hungry. I have a few bites and I’m done.”

On the surface, that may feel like a dream after years of battling cravings. But it also means every bite has to count.

A simple framework I like to use with clients is a balanced plate (which you can download here):

  • ½ plate: colourful vegetables and fibre rich plants
  • ¼ plate: high quality protein
  • ¼ plate: slow release carbohydrates
  • Plus a small portion of healthy fats

When portions are smaller, the order in which you eat also matters. I often suggest starting with protein, then working your way around the plate. Protein is critical for:

  • Preserving lean muscle
  • Supporting hair, skin and nail health
  • Maintaining immune function
  • Keeping you fuller between meals

Healthy fats and slow release carbs then help support:

  • Hormone balance (especially through peri and menopause)
  • Gallbladder and bile flow
  • Stable energy and blood sugar

Inside the program, I give clear protein targets, food ideas and “mini-meals” for those days when a full plate simply feels like too much. The goal is never perfection, it is about making small tweaks that have a big impact when you are eating less overall.

Pillar 2: Digestion That Works With Your Medication, Not Against It

Because GLP-1 and GIP based weight loss medications slow gastric emptying, your digestion needs extra TLC.

Without support, it’s common to experience:

  • Nausea
  • Bloating or early fullness
  • Reflux or heartburn
  • Constipation (or, less commonly, diarrhoea)

A few principles we work with in the program:

Smaller, more frequent meals

Your stomach cannot handle the same volume as before. Eating every 3–4 hours in smaller amounts is often far more comfortable.

Chewing thoroughly and eating mindfully

It sounds basic, but slow eating is one of the most effective “digestive supplements” I know.

Understanding your personal triggers

For many people, these include coffee, fizzy drinks, rich or fatty meals, spicy food, or acidic foods. It’s not about banning everything, it is about learning what your gut currently tolerates.

We also look at gentle ways to support regular bowel movements (using specific fibres, hydration and movement). There’s a whole module dedicated just to digestion and side effect support because feeling bloated and miserable after every meal is not the goal.

Pillar 3: Supporting Liver & Gallbladder, Your “Housekeeping Team”

As the scales move down, your liver and gallbladder are working incredibly hard behind the scenes:

  • Metabolising the medication
  • Processing released hormones and stored compounds from fat loss
  • Producing and storing bile to digest fats
  • Absorbing fat soluble vitamins

If bile flow becomes sluggish, which can happen when you are barely eating any fat, or when weight loss is rapid, you may notice:

  • Nausea or a “heavy” feeling after meals
  • Discomfort under the right side of the rib cage
  • Pale, floating or greasy stools
  • Bloating or reflux

In the program, we explore how to gently:

  • Include small, regular portions of healthy fats to keep bile moving
  • Use bitter foods to support bile flow naturally
  • Stay well hydrated so bile doesn’t thicken
  • Reduce liver load from alcohol and unnecessary additives / toxins

We also discuss red flags that mean you should seek medical help rather than “pushing through.”

From a functional medicine perspective, this is a crucial piece of protecting your long term health while using powerful weight-loss medications.

Pillar 4: Sleep, Stress & Emotional Eating. Your Hormonal Control Panel

You can eat beautifully and be on the right dose of medication, but if your sleep is poor or your stress levels are chronically high, your metabolism will feel it.

Poor sleep and stress can:

  • Lower your natural GLP-1 levels
  • Increase cravings
  • Raise cortisol
  • Reduce insulin sensitivity
  • Make blood sugar more erratic

In the program we cover:

Night time blood sugar dips

Why waking between 2–4 a.m. with a racing heart or anxiety can be related to your evening meal.

Simple circadian rhythm resets

Morning light exposure, consistent sleep/wake times, aligning meals with daylight hours.

Nutrition for calm and sleep

Foods rich in tryptophan & magnesium.

Nervous system support

Gentle practices that strengthen parasympathetic tone, your “rest and digest” mode.

We also talk honestly about emotional eating.

Weight loss medications can quieten physical hunger, but they don’t resolve stress, boredom, overwhelm or old coping patterns.

Learning to meet these needs directly, not with food, is a huge part of long term transformation.

Pillar 5: Movement as Medicine. Protecting Muscle & Metabolism

One of the biggest risks with rapid weight loss is losing muscle, not just fat.

Muscle is metabolically active. It:

  • Keeps your resting metabolism higher
  • Supports stable blood sugar
  • Protects joints and bones
  • Boosts mood and energy

Without movement, you may lose weight now… but find it far easier to regain it later, especially when medications stop.

In the movement module, we focus on:

  • Gentle aerobic activity
  • Simple resistance training 2–3 times per week
  • Flexibility and mind–body work to support recovery and stress regulation

We build from wherever you are, whether you haven’t exercised in years or you are already active but want to do it safely while your appetite is lower.

You Don’t Have to Figure This Out Alone

If you’re reading this, you’re already taking an important step by thinking beyond the injection and considering how to support your body as a whole.

Many people find it helpful to have clear, evidence informed guidance that respects the role of these medications, protects long term health, and translates complex information into practical, realistic steps. This is the approach I take in my 7-module group programme, where each of these pillars is explored in more depth with structured lessons, tools, and resources to support day-to-day implementation.

If you’d like to learn more about the Beyond the Injection Group Programme, you can find additional details here and decide whether it feels like the right fit for you.

References:

  1. Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity (Silver Spring). 2025 May 30. doi: 10.1002/oby.24336. Epub ahead of print. PMID: 40445127.
  2. Christensen, S. Robinson, K, Thomas, S. Williams, D.R. Dietary intake by patients taking GLP-1 and dual GIP/GLP-1 receptor agonists: a narrative review and discussion of research needs, Obes Pillars 11 (2024) 100121.
  3. Chavez AM, Carrasco Barria R, León-Sanz M. Nutrition support whilst on glucagon-like peptide 1 based therapy. Is it necessary? Curr Opin Clin Nutr Metab Care. 2025 Jul 1;28(4):351-357. doi: 10.1097/MCO.0000000000001130. Epub 2025 May 2. PMID: 40401903.
  4. J.P. Almandoz, T.A. Wadden, C. Tewksbury, C.M. Apovian, A. Fitch, J.D. Ard, Z. Li, J. Richards, W.S. Butsch, I. Jouravskaya, et al., Nutritional considerations with antiobesity medications, Obesity (Silver Spring) 32 (9) (2024) 1613–1631.
  5. H.J. Leidy, P.M. Clifton, A. Astrup, T.P. Wycherley, M.S. Westerterp- Plantenga, N.D. Luscombe-Marsh, et al., The role of protein in weight loss and maintenance, Am. J. Clin. Nutr. 101 (6) (2015) 1320S1329S.
  6. Kelli M. Richardson et al. The influence of the glucagon-like peptide-1 receptor agonist, liraglutide, on dietary patterns and nutrient intakes in patients with obesity and prediabetes: A secondary analysis of a randomized controlled trial. Diabetes Obes Metab. 2025 Jul;27(7):3725-3735. doi: 10.1111/dom.16395. Epub 2025 Apr 21.
  7. Prado, Carla M et al. Muscle matters: the effects of medically induced weight loss on skeletal muscle. The Lancet Diabetes & Endocrinology, 2024 Volume 12, Issue 11, 785 – 787. https://pubmed.ncbi.nlm.nih.gov/39265590/
  8. Conte C, Hall KD, Klein S. Is Weight Loss–Induced Muscle Mass Loss Clinically Relevant? JAMA. 2024;332(1):9–10. doi:10.1001/jama.2024.6586
  9. Cava E, Yeat NC, Mittendorfer B. Preserving Healthy Muscle during Weight Loss. Adv Nutr. 2017 May 15;8(3):511-519. doi: 10.3945/an.116.014506. PMID: 28507015; PMCID: PMC5421125.
  10. McCarthy D, Berg A. Weight Loss Strategies and the Risk of Skeletal Muscle Mass Loss. Nutrients. 2021 Jul 20;13(7):2473. doi: 10.3390/nu13072473. PMID: 34371981; PMCID: PMC8308821.
  11. S.B.K. Jensen, V. Sorensen, R.M. Sandsdal, E.W. Lehmann, J.R. Lundgren, C.R. Juhl, C. Janus, T. Ternhamar, B.M. Stallknecht, J.J. Holst, et al., Bone health after exercise alone, GLP 1 receptor agonist treatment, or combination treatment: a secondary analysis of a randomized clinical trial, JAMA Netw. Open 7 (6) (2024) e2416775.
  12. Jensen SBK, Blond MB, Sandsdal RM, et al. Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post treatment analysis of a randomised placebo-controlled trial. EClinical Medicine. 2024; 69:102475. doi:10.1016/j.eclinm.2024.102475
  13. G. Beccuti, S. Pannain, Sleep and obesity, Curr. Opin. Clin. Nutr.Metab. Care 14 (4) (2011) 402–412.
  14. K.A. Scott, S.J. Melhorn, R.R. Sakai, Effects of chronic socialstress on obesity, Curr. Obes. Rep. 1 (1) (2012) 16–25.
  15. J.M. Greeson, G.R. Chin, Mindfulness and physical disease: aconcise review, Curr. Opin. Psychol. 28 (2019) 204–210.
Posted in

Leave a Comment